
BLAST2 result
BLASTP 2.2.2 [Dec-14-2001]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Query= TM0175.7
(402 letters)
Database: sprot
164,201 sequences; 59,974,054 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
PRTZ_HORVU (P06293) Protein Z (Z4) (Major endosperm albumin) 295 2e-79
ANT3_MOUSE (P32261) Antithrombin-III precursor (ATIII) 181 4e-45
ANT3_HUMAN (P01008) Antithrombin-III precursor (ATIII) (PRO0309) 177 4e-44
SB10_HUMAN (P48595) Bomapin (Protease inhibitor 10) (Serpin B10) 177 6e-44
NEUS_CHICK (Q90935) Neuroserpin precursor (Axonin-2) 176 7e-44
NEUS_RAT (Q9JLD2) Neuroserpin precursor (Protease inhibitor 17) 172 2e-42
ANT3_SHEEP (P32262) Antithrombin-III precursor (ATIII) 171 2e-42
ANT3_BOVIN (P41361) Antithrombin-III (ATIII) 168 2e-41
PAI2_HUMAN (P05120) Plasminogen activator inhibitor-2 precursor ... 163 6e-40
SCC2_HUMAN (P48594) Squamous cell carcinoma antigen 2 (SCCA-2) (... 162 1e-39
ILEU_PIG (P80229) Leukocyte elastase inhibitor (LEI) (Leucocyte ... 161 2e-39
SPB9_HUMAN (P50453) Cytoplasmic antiproteinase 3 (CAP3) (CAP-3) ... 160 7e-39
NEUS_HUMAN (Q99574) Neuroserpin precursor (Protease inhibitor 12) 160 7e-39
ILEU_HUMAN (P30740) Leukocyte elastase inhibitor (LEI) (Monocyte... 156 8e-38
NEUS_MOUSE (O35684) Neuroserpin precursor (Protease inhibitor 17) 155 2e-37
PTI6_HUMAN (P35237) Placental thrombin inhibitor (Cytoplasmic an... 154 5e-37
PAI1_RAT (P20961) Plasminogen activator inhibitor-1 precursor (P... 153 9e-37
SCC1_HUMAN (P29508) Squamous cell carcinoma antigen 1 (SCCA-1) (... 152 1e-36
SPB8_HUMAN (P50452) Cytoplasmic antiproteinase 2 (CAP2) (CAP-2) ... 152 1e-36
PAI1_MUSVI (P50449) Plasminogen activator inhibitor-1 precursor ... 152 2e-36
>PRTZ_HORVU (P06293) Protein Z (Z4) (Major endosperm albumin)
Length = 399
Score = 295 bits (754), Expect = 2e-79
Identities = 172/393 (43%), Positives = 246/393 (61%), Gaps = 11/393 (2%)
Query: 2 DLQKSIRCQTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSF 61
D++ SI QT AL + + S E N+ FSP SLH LS++ G+A +T D+L +
Sbjct: 8 DVRLSIAHQTRFALRLRSAISSNPERAAGNVAFSPLSLHVALSLITAGAA-ATRDQLVAI 66
Query: 62 LR---FDSVDHLNTFFSQVLSTVLSD--TTPSFLLSFVNEMWADKSLALSHSFKQLMTTH 116
L LN QV+ VL++ +T ++F N ++ D SL+L SF++L
Sbjct: 67 LGDGGAGDAKELNALAEQVVQFVLANESSTGGPRIAFANGIFVDASLSLKPSFEELAVCQ 126
Query: 117 YKATLALVDFRTKGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVW 176
YKA VDF+ K + +VNSWVE+ T GLI ++LP +V TKLI NALYFKG W
Sbjct: 127 YKAKTQSVDFQHKTLEAVGQVNSWVEQVTTGLIKQILPPGSVDNTTKLILGNALYFKGAW 186
Query: 177 KHTFDPSMTFVDDFHLLNGTSIEVPFMSSEKKTQFIRTFDGFNVLRLSYKQGRDKKLRFS 236
FD S T D FHLL+G+SI+ FMSS KK Q+I + D VL+L Y +G DK+ +FS
Sbjct: 187 DQKFDESNTKCDSFHLLDGSSIQTQFMSSTKK-QYISSSDNLKVLKLPYAKGHDKR-QFS 244
Query: 237 MCIFLPNAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKEL 296
M I LP A+DGL SL ++L++E F++ +P+Q V V +F++PKFKI ++ EAS++L+ L
Sbjct: 245 MYILLPGAQDGLWSLAKRLSTEPEFIENHIPKQTVEVGRFQLPKFKISYQFEASSLLRAL 304
Query: 297 GVVSPFSKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSAR 356
G+ PFS+ A+ ++MV S L + + HK+ +EVNEEGTEAG A V + + +
Sbjct: 305 GLQLPFSE-EADLSEMVDSS-QGLEISHVFHKSFVEVNEEGTEAGAATVAMGVAMSMPLK 362
Query: 357 TG-IDFVADHPFLFLIREDLTGTILFIGQVLHP 388
+DFVA+HPFLFLIRED+ G ++F+G V +P
Sbjct: 363 VDLVDFVANHPFLFLIREDIAGVVVFVGHVTNP 395
>ANT3_MOUSE (P32261) Antithrombin-III precursor (ATIII)
Length = 465
Score = 181 bits (458), Expect = 4e-45
Identities = 112/386 (29%), Positives = 194/386 (50%), Gaps = 14/386 (3%)
Query: 8 RCQTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSV 67
+ + A + +HL + + N+ SP S+ ++ +G+ TL +L +FD++
Sbjct: 86 KANSRFATNFYQHLADSKNDND-NIFLSPLSISTAFAMTKLGACNDTLKQLMEVFKFDTI 144
Query: 68 -----DHLNTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLA 122
D ++ FF+++ + S L N ++ DKSL + S++ + Y A L
Sbjct: 145 SEKTSDQIHFFFAKLNCRLYRKANKSSDLVSANRLFGDKSLTFNESYQDVSEVVYGAKLQ 204
Query: 123 LVDFRTKGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDP 182
+DF+ +Q +N+WV +T G I +++P A+++LT L+ N +YFKG+WK F P
Sbjct: 205 PLDFKENPEQSRVTINNWVANKTEGRIKDVIPQGAINELTALVLVNTIYFKGLWKSKFSP 264
Query: 183 SMTFVDDFHLLNGTSIEVPFMSSEKKTQFIRTFDGFNVLRLSYKQGRDKKLRFSMCIFLP 242
T + F+ ++G S VP M E K ++ R +G VL L +K G D +M + LP
Sbjct: 265 ENTRKEPFYKVDGQSCPVPMMYQEGKFKYRRVAEGTQVLELPFK-GDD----ITMVLILP 319
Query: 243 NAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPF 302
+ L + ++L E L+ L + +P+F+ L+++G++ F
Sbjct: 320 KPEKSLAKVEQELTPE--LLQEWLDELSETMLVVHMPRFRTEDGFSLKEQLQDMGLIDLF 377
Query: 303 SKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFV 362
S + +V D+L V HKA +EVNEEG+EA + S+ ++ + F
Sbjct: 378 SPEKSQLPGIVAGGRDDLYVSDAFHKAFLEVNEEGSEAAASTSVVITGRSLNPNR-VTFK 436
Query: 363 ADHPFLFLIREDLTGTILFIGQVLHP 388
A+ PFL LIRE TI+F+G+V +P
Sbjct: 437 ANRPFLVLIREVALNTIIFMGRVANP 462
>ANT3_HUMAN (P01008) Antithrombin-III precursor (ATIII) (PRO0309)
Length = 464
Score = 177 bits (449), Expect = 4e-44
Identities = 110/386 (28%), Positives = 193/386 (49%), Gaps = 14/386 (3%)
Query: 8 RCQTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSV 67
+ + A + +HL + + N+ SP S+ ++ +G+ TL +L +FD++
Sbjct: 85 KANSRFATTFYQHLADSKNDND-NIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTI 143
Query: 68 -----DHLNTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLA 122
D ++ FF+++ + S L N ++ DKSL + +++ + Y A L
Sbjct: 144 SEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQ 203
Query: 123 LVDFRTKGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDP 182
+DF+ +Q +N WV +T G IT+++P+ A+++LT L+ N +YFKG+WK F P
Sbjct: 204 PLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSP 263
Query: 183 SMTFVDDFHLLNGTSIEVPFMSSEKKTQFIRTFDGFNVLRLSYKQGRDKKLRFSMCIFLP 242
T + F+ +G S M E K ++ R +G VL L +K G D +M + LP
Sbjct: 264 ENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFK-GDD----ITMVLILP 318
Query: 243 NAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPF 302
+ L + ++L E L+ L + + +P+F+I L+++G+V F
Sbjct: 319 KPEKSLAKVEKELTPE--VLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLF 376
Query: 303 SKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFV 362
S + +V D+L V HKA +EVNEEG+EA + ++ ++ + F
Sbjct: 377 SPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNR-VTFK 435
Query: 363 ADHPFLFLIREDLTGTILFIGQVLHP 388
A+ PFL IRE TI+F+G+V +P
Sbjct: 436 ANRPFLVFIREVPLNTIIFMGRVANP 461
>SB10_HUMAN (P48595) Bomapin (Protease inhibitor 10) (Serpin B10)
Length = 397
Score = 177 bits (448), Expect = 6e-44
Identities = 120/400 (30%), Positives = 201/400 (50%), Gaps = 35/400 (8%)
Query: 12 EVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFD------ 65
+ AL ++K L E Q KN+ FS +S+ L+++ +G+ G+T ++ L+F+
Sbjct: 10 QFALELSKKL--AESAQGKNIFFSSWSISTSLTIVYLGAKGTTAAQMAQVLQFNRDQGVK 67
Query: 66 ----------------SVDHLNTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSF 109
+ + +++ F ++S +L +LL N ++ +K+ A + +
Sbjct: 68 CDPESEKKRKMEFNLSNSEEIHSDFQTLISEILKPND-DYLLKTANAIYGEKTYAFHNKY 126
Query: 110 KQLMTTHYKATLALVDFRTKGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANA 169
+ M T++ A V+F DQ+ +++NSWVE++T G I LLP ++V T++I NA
Sbjct: 127 LEDMKTYFGAEPQPVNFVEASDQIRKDINSWVERQTEGKIQNLLPDDSVDSTTRMILVNA 186
Query: 170 LYFKGVWKHTFDPSMTFVDDFHLLNGTSIEVPFMSSEKKTQFIRTFDGFNVLRLSYKQGR 229
LYFKG+W+H F T F + TS V M +KK V Y + R
Sbjct: 187 LYFKGIWEHQFLVQNTTEKPFRINETTSKPVQMMFMKKKLHIFHIEKPKAVGLQLYYKSR 246
Query: 230 DKKLRFSMCIFLPNAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEA 289
D S+ I LP +GL L + + E ++ + +PKFK+ +
Sbjct: 247 D----LSLLILLPEDINGLEQLEKAITYEKLNEWTSADMMELYEVQLHLPKFKLEDSYDL 302
Query: 290 SNVLKELGVVSPFSKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVAC-SMCD 348
+ L +G+ FS+S A+F+ M S L + ++ HKA +E+NE+GTEA S D
Sbjct: 303 KSTLSSMGMSDAFSQSKADFSGM--SSARNLFLSNVFHKAFVEINEQGTEAAAGSGSEID 360
Query: 349 VKLCVSARTGIDFVADHPFLFLIREDLTGTILFIGQVLHP 388
+++ V + I+F A+HPFLF IR + T TILF G++ P
Sbjct: 361 IRIRVPS---IEFNANHPFLFFIRHNKTNTILFYGRLCSP 397
>NEUS_CHICK (Q90935) Neuroserpin precursor (Axonin-2)
Length = 410
Score = 176 bits (447), Expect = 7e-44
Identities = 123/390 (31%), Positives = 199/390 (50%), Gaps = 25/390 (6%)
Query: 10 QTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDH 69
+T LS+ + + +++N++F P S+ + ++ +G+ G+TL E+ L FDS+ +
Sbjct: 24 ETIAELSVNVYNQLRAAREDENILFCPLSIAIAMGMIELGAHGTTLKEIRHSLGFDSLKN 83
Query: 70 LNTF-FSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRT 128
F F + LS + + ++L+ N ++ +S F QL+ ++KA + +DF +
Sbjct: 84 GEEFTFLKDLSDMATTEESHYVLNMANSLYVQNGFHVSEKFLQLVKKYFKAEVENIDF-S 142
Query: 129 KGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVD 188
+ V +N WVE TN +I + + + LT L+ NA+YFKG WK F P T
Sbjct: 143 QSAAVATHINKWVENHTNNMIKDFVSSRDFSALTHLVLINAIYFKGNWKSQFRPENTRTF 202
Query: 189 DFHLLNGTSIEVPFMSSEKKTQFIRTFDGFN-------VLRLSYKQGRDKKLRFSMCIFL 241
F + T +++P M + + + DG N VL + Y+ SM I L
Sbjct: 203 SFTKDDETEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGD-----EISMMIVL 257
Query: 242 PNAKDGLPSLIEKLASESCFLK--GKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVV 299
+ L +L E L S + + +QKV V +P+F + E++ +VLK LG+
Sbjct: 258 SRQEVPLVTL-EPLVKASLINEWANSVKKQKVEV---YLPRFTVEQEIDLKDVLKGLGIT 313
Query: 300 SPFSKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGI 359
FS+S A+ T M S EL + HKA +EVNEEG+EA A M + + A
Sbjct: 314 EVFSRS-ADLTAM--SDNKELYLAKAFHKAFLEVNEEGSEAAAASGM--IAISRMAVLYP 368
Query: 360 DFVADHPFLFLIREDLTGTILFIGQVLHPE 389
+ DHPF FL+R TGT+LF+G+V+HPE
Sbjct: 369 QVIVDHPFFFLVRNRRTGTVLFMGRVMHPE 398
>NEUS_RAT (Q9JLD2) Neuroserpin precursor (Protease inhibitor 17)
Length = 410
Score = 172 bits (435), Expect = 2e-42
Identities = 126/397 (31%), Positives = 202/397 (50%), Gaps = 45/397 (11%)
Query: 12 EVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLN 71
E ++++ HL + E ++N++FSP S+ + VM +G+ GSTL E+ + ++S+
Sbjct: 28 EWSVNVYNHLRATGE--DENILFSPLSIALAMGVMELGAQGSTLKEIRHSMGYESLKSGE 85
Query: 72 TF-FSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKG 130
F F + S+++S +++ N ++ ++ F Q+M ++ A + VDF ++
Sbjct: 86 EFSFLRDFSSMVSAEEGQYVMKIANSLFVQNGFHINEEFLQMMKMYFNAEVNHVDF-SEN 144
Query: 131 DQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDF 190
V +N WVE TN L+ +L+ +T L NA+YFKG WK F P T F
Sbjct: 145 VAVANYINKWVENYTNSLLKDLVSPGDFDAVTHLALINAVYFKGNWKSQFRPENTRTFSF 204
Query: 191 HLLNGTSIEVPFMSSEKKTQFIRTFDGFN-------VLRLSYKQGRDKKLRFSMCIFLPN 243
+ + +++P M + + + DG N VL + Y+ SM + L
Sbjct: 205 TKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGD-----EISMMLVLSR 259
Query: 244 AKDGL--------PSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKE 295
+ L P LIE+ A+ + +QKV V +P+F + E++ ++LK
Sbjct: 260 QEVPLATLEPLLKPQLIEEWAN-------SVKKQKVEV---YLPRFTVEQEIDLKDILKA 309
Query: 296 LGVVSPFSKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSA 355
LGV F K +AN T M S EL + HK+ IEVNEEG+EA VA M + +
Sbjct: 310 LGVTEIFIK-DANLTAM--SDKKELFLSKAVHKSFIEVNEEGSEAAVASGMIAI-----S 361
Query: 356 RTGIDF---VADHPFLFLIREDLTGTILFIGQVLHPE 389
R + F + DHPFLFLI+ TGTILF+G+V+HPE
Sbjct: 362 RMAVLFPQVIVDHPFLFLIKNRKTGTILFMGRVMHPE 398
>ANT3_SHEEP (P32262) Antithrombin-III precursor (ATIII)
Length = 465
Score = 171 bits (434), Expect = 2e-42
Identities = 107/386 (27%), Positives = 189/386 (48%), Gaps = 14/386 (3%)
Query: 8 RCQTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSV 67
+ + A + +HL + + N+ SP S+ ++ +G+ +TL +L +FD++
Sbjct: 86 KANSHFATAFYQHLADSKNNND-NIFLSPLSISTAFAMTKLGACNNTLKQLMEVFKFDTI 144
Query: 68 -----DHLNTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLA 122
D ++ FF+++ + S L N ++ DKS+ + +++ + Y A L
Sbjct: 145 SEKTSDQIHFFFAKLNCRLYRKANKSSELVSANRLFGDKSITFNETYQDISEVVYGAKLQ 204
Query: 123 LVDFRTKGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDP 182
+DF+ +Q +N W+ +T G IT+++P A+ + T L+ N +YFKG+WK F P
Sbjct: 205 PLDFKGNAEQSRLTINQWISNKTEGRITDVIPPQAIDEFTVLVLVNTIYFKGLWKSKFSP 264
Query: 183 SMTFVDDFHLLNGTSIEVPFMSSEKKTQFIRTFDGFNVLRLSYKQGRDKKLRFSMCIFLP 242
T + F+ +G S VP M E K ++ R +G VL L +K G D +M + LP
Sbjct: 265 ENTKKELFYKADGESCSVPMMYQEGKFRYRRVAEGTQVLELPFK-GDD----ITMVLILP 319
Query: 243 NAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPF 302
+ L + +L + L+ L + +P F+I L+++G+ F
Sbjct: 320 KLEKPLAKVERELTPD--MLQEWLDELTETLLVVHMPHFRIEDSFSVKEQLQDMGLEDLF 377
Query: 303 SKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFV 362
S + +V ++L V HKA +EVNEEG+EA + + ++ + F
Sbjct: 378 SPEKSRLPGIVAEGRNDLYVSDAFHKAFLEVNEEGSEAAASTVISIAGRSLNLNR-VTFQ 436
Query: 363 ADHPFLFLIREDLTGTILFIGQVLHP 388
A+ PFL LIRE TI+F+G+V +P
Sbjct: 437 ANRPFLVLIREVALNTIIFMGRVANP 462
>ANT3_BOVIN (P41361) Antithrombin-III (ATIII)
Length = 433
Score = 168 bits (426), Expect = 2e-41
Identities = 105/386 (27%), Positives = 190/386 (49%), Gaps = 14/386 (3%)
Query: 8 RCQTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSV 67
+ + A + +HL + + N+ SP S+ ++ +G+ +TL +L +FD++
Sbjct: 54 KANSHFATAFYQHLADSKNNND-NIFLSPLSISTAFAMTKLGACNNTLTQLMEVFKFDTI 112
Query: 68 -----DHLNTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLA 122
D ++ FF+++ + S L N ++ DKS+ + +++ + Y A L
Sbjct: 113 SEKTSDQIHFFFAKLNCRLYRKANKSSELVSANRLFGDKSITFNETYQDISEVVYGAKLQ 172
Query: 123 LVDFRTKGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDP 182
+DF+ +Q +N W+ +T G IT+++P A+++ T L+ N +YFKG+WK F P
Sbjct: 173 PLDFKGNAEQSRLTINQWISNKTEGRITDVIPPQAINEFTVLVLVNTIYFKGLWKSKFSP 232
Query: 183 SMTFVDDFHLLNGTSIEVPFMSSEKKTQFIRTFDGFNVLRLSYKQGRDKKLRFSMCIFLP 242
T + F+ +G S V M E K ++ R + VL L +K G D +M + LP
Sbjct: 233 ENTRKELFYKADGESCSVLMMYQESKFRYRRVAESTQVLELPFK-GDD----ITMVLILP 287
Query: 243 NAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPF 302
+ L + ++L + L+ L + +P+F+I L+++G+ F
Sbjct: 288 KLEKTLAKVEQELTPD--MLQEWLDELTETLLVVHMPRFRIEDSFSVKEQLQDMGLEDLF 345
Query: 303 SKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFV 362
S + +V +L V HKA +EVNEEG+EA + + +++ + F
Sbjct: 346 SPEKSRLPGIVAEGRSDLYVSDAFHKAFLEVNEEGSEAAASTVISIAGRSLNS-DRVTFK 404
Query: 363 ADHPFLFLIREDLTGTILFIGQVLHP 388
A+ PFL LIRE TI+F+G+V +P
Sbjct: 405 ANRPFLVLIREVALNTIIFMGRVANP 430
>PAI2_HUMAN (P05120) Plasminogen activator inhibitor-2 precursor
(PAI-2) (Placental plasminogen activator inhibitor)
(Monocyte Arg-serpin) (Urokinase inhibitor)
Length = 415
Score = 163 bits (413), Expect = 6e-40
Identities = 121/424 (28%), Positives = 205/424 (47%), Gaps = 63/424 (14%)
Query: 11 TEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSV--- 67
T AL++ KHL Q NL SP+S+ + ++++ +GS GST D++ L+F+ V
Sbjct: 9 TLFALNLFKHLAKASPTQ--NLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAN 66
Query: 68 ----------------------------------DHLNTFFSQVLSTVLSDTTPSFLLSF 93
D +++ F LS+ ++ +T ++LL
Sbjct: 67 AVTPMTPENFTSCGFMQQIQKGSYPDAILQAQAADKIHSSFRS-LSSAINASTGNYLLES 125
Query: 94 VNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQVCREVNSWVEKETNGLITELL 153
VN+++ +KS + + +L +Y + VDF ++ +++NSWV+ +T G I LL
Sbjct: 126 VNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLL 185
Query: 154 PTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHLLNG--TSIEVPFMSSEKKTQF 211
P +V T+++ NA+YFKG WK F+ + + F + + T +++ ++ + +
Sbjct: 186 PEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGY 245
Query: 212 IRTFDGFNVLRLSYKQGRDKKLRFSMCIFLPNAKDGLPSLIEKLASESCF-------LKG 264
I +L L Y SM + LP+ + + +E L SE + K
Sbjct: 246 IEDLKA-QILELPYAGD------VSMFLLLPDEIADVSTGLELLESEITYDKLNKWTSKD 298
Query: 265 KLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSNANFTKMVVSPLDELCVES 324
K+ +V V IP+FK+ E ++L+ +G+ F+K ANF+ M S ++L +
Sbjct: 299 KMAEDEVEV---YIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGM--SERNDLFLSE 353
Query: 325 IHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVADHPFLFLIREDLTGTILFIGQ 384
+ H+A ++VNEEGTEA A V + G FVADHPFLFLI +T ILF G+
Sbjct: 354 VFHQAMVDVNEEGTEA--AAGTGGVMTGRTGHGGPQFVADHPFLFLIMHKITNCILFFGR 411
Query: 385 VLHP 388
P
Sbjct: 412 FSSP 415
>SCC2_HUMAN (P48594) Squamous cell carcinoma antigen 2 (SCCA-2)
(Leupin)
Length = 390
Score = 162 bits (411), Expect = 1e-39
Identities = 112/386 (29%), Positives = 185/386 (47%), Gaps = 43/386 (11%)
Query: 28 QEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLNTFFS------------ 75
+E N+ +SP S+ + L ++ +G+ +T ++ L FD V T +
Sbjct: 23 KENNIFYSPISITSALGMVLLGAKDNTAQQISKVLHFDQVTENTTEKAATYHVDRSGNVH 82
Query: 76 ---QVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQ 132
Q L T + +T ++ L N+++ +K+ + + Y+ ++ DF ++
Sbjct: 83 HQFQKLLTEFNKSTDAYELKIANKLFGEKTYQFLQEYLDAIKKFYQTSVESTDFANAPEE 142
Query: 133 VCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHL 192
+++NSWVE +TN I L P + T L+ NA+YFKG W++ F T + F
Sbjct: 143 SRKKINSWVESQTNEKIKNLFPDGTIGNDTTLVLVNAIYFKGQWENKFKKENTKEEKFW- 201
Query: 193 LNGTSIEVPFMSSEKKTQFIRTFDGFN----------VLRLSYKQGRDKKLRFSMCIFLP 242
P ++ K Q +R ++ FN VL + YK G+D SM + LP
Sbjct: 202 --------PNKNTYKSVQMMRQYNSFNFALLEDVQAKVLEIPYK-GKD----LSMIVLLP 248
Query: 243 NAKDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPF 302
N DGL L EKL +E L + +P+FK+ + + L+ +G+V+ F
Sbjct: 249 NEIDGLQKLEEKLTAEKLMEWTSLQNMRETCVDLHLPRFKMEESYDLKDTLRTMGMVNIF 308
Query: 303 SKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFV 362
+ +A+ + M S L V + HKA +EV EEG EA A ++ V+L S T +F
Sbjct: 309 N-GDADLSGMTWS--HGLSVSKVLHKAFVEVTEEGVEAAAATAVVVVELS-SPSTNEEFC 364
Query: 363 ADHPFLFLIREDLTGTILFIGQVLHP 388
+HPFLF IR++ T +ILF G+ P
Sbjct: 365 CNHPFLFFIRQNKTNSILFYGRFSSP 390
>ILEU_PIG (P80229) Leukocyte elastase inhibitor (LEI) (Leucocyte
neutral proteinase inhibitor) (LNPI)
Length = 378
Score = 161 bits (408), Expect = 2e-39
Identities = 122/384 (31%), Positives = 189/384 (48%), Gaps = 20/384 (5%)
Query: 11 TEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHL 70
T AL + + L E N+ SPFS+ + L+++ +G+ G+T ++ L FD+V +
Sbjct: 9 TRFALDLFRAL--NESNPAGNIFISPFSISSALAMILLGTRGNTEAQMSKALHFDTVKDI 66
Query: 71 NTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKG 130
++ F Q L+ ++ S++L N ++ +K+ F Y A LA VDF
Sbjct: 67 HSRF-QSLNADINKCGASYILKLANRLFGEKTYHFLPEFLASTQKTYGAELASVDFLRAS 125
Query: 131 DQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDF 190
++ + +N WV+++T G I ELL + V TKL+ NA+YFKG W+ F T F
Sbjct: 126 EEARKAINEWVKEQTEGKIPELLASGVVDSATKLVLVNAIYFKGSWQEKFMTEATKDAPF 185
Query: 191 HLLNGTSIEVPFMSSEKKTQF--IRTFDGFNVLRLSYKQGRDKKLRFSMCIFLPNA---- 244
L S V M +KK F I+ VL L Y QG+D SM I LP++
Sbjct: 186 RLNKKDSKTVKMMYQKKKFPFGYIKELK-CRVLELPY-QGKD----LSMVILLPDSIEDE 239
Query: 245 KDGLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSK 304
GL + + L E K ++ +P+F++ + + L LGV F
Sbjct: 240 STGLRKIEQHLTLEKLNEWTKPDNLELLEVNVHLPRFRLEESYDLNAPLARLGVQDLFG- 298
Query: 305 SNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVAD 364
S A+ T M S +L + + HKA +EVNEEGTEA A + + + DF+AD
Sbjct: 299 SRADLTGM--SEARDLFISKVVHKAFVEVNEEGTEA--AAATAGIAVFAMLMPEEDFIAD 354
Query: 365 HPFLFLIREDLTGTILFIGQVLHP 388
HPF+F IR + + ILF+G++ P
Sbjct: 355 HPFIFFIRHNPSSNILFLGRLSSP 378
>SPB9_HUMAN (P50453) Cytoplasmic antiproteinase 3 (CAP3) (CAP-3)
(Protease inhibitor 9) (Serpin B9)
Length = 376
Score = 160 bits (404), Expect = 7e-39
Identities = 107/359 (29%), Positives = 176/359 (48%), Gaps = 10/359 (2%)
Query: 31 NLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLNTFFSQVLSTVLSDTTPSFL 90
N+ SP S+ + L+++ +G+ G+T ++ L ++ + ++ F +L+ V T +L
Sbjct: 27 NVFCSPVSISSALAMVLLGAKGNTATQMAQALSLNTEEDIHRAFQSLLTEVNKAGT-QYL 85
Query: 91 LSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQVCREVNSWVEKETNGLIT 150
L N ++ +K+ +FK+ Y A L + F ++ + +N+WV K+T G I
Sbjct: 86 LRTANRLFGEKTCQFLSTFKESCLQFYHAELKELSFIRAAEESRKHINTWVSKKTEGKIE 145
Query: 151 ELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHLLNGTSIEVPFMSSEKKTQ 210
ELLP +++ T+L+ NA+YFKG W FD + T F + V M E +
Sbjct: 146 ELLPGSSIDAETRLVLVNAIYFKGKWNEPFDETYTREMPFKINQEEQRPVQMMYQEATFK 205
Query: 211 FIRTFD-GFNVLRLSYKQGRDKKLRFSMCIFLPNAKDGLPSLIEKLASESCFLKGKLPRQ 269
+ +L L Y + S+ + LP+ L ++ + L E K
Sbjct: 206 LAHVGEVRAQLLELPY-----ARKELSLLVLLPDDGVELSTVEKSLTFEKLTAWTKPDCM 260
Query: 270 KVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSNANFTKMVVSPLDELCVESIHHKA 329
K + +PKFK+ + + +VL+ LG+V F + A+ + M S +LC+ HK+
Sbjct: 261 KSTEVEVLLPKFKLQEDYDMESVLRHLGIVDAFQQGKADLSAM--SAERDLCLSKFVHKS 318
Query: 330 SIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVADHPFLFLIREDLTGTILFIGQVLHP 388
+EVNEEGTEA A S V C +G F ADHPFLF IR + +ILF G+ P
Sbjct: 319 FVEVNEEGTEAAAASSCFVVAEC-CMESGPRFCADHPFLFFIRHNRANSILFCGRFSSP 376
>NEUS_HUMAN (Q99574) Neuroserpin precursor (Protease inhibitor 12)
Length = 410
Score = 160 bits (404), Expect = 7e-39
Identities = 114/385 (29%), Positives = 190/385 (48%), Gaps = 25/385 (6%)
Query: 15 LSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLNTF- 73
LS+ + + +++N++FSP S+ + +M +G+ GST E+ + +DS+ + F
Sbjct: 29 LSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFS 88
Query: 74 FSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQV 133
F + S +++ +++ N ++ ++ F Q+M ++ A + VDF ++ V
Sbjct: 89 FLKEFSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDF-SQNVAV 147
Query: 134 CREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHLL 193
+N WVE TN L+ +L+ T L NA+YFKG WK F P T F
Sbjct: 148 ANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKD 207
Query: 194 NGTSIEVPFMSSEKKTQFIRTFDGFN-------VLRLSYKQGRDKKLRFSMCIFLPNAKD 246
+ + +++P M + + + DG N VL + Y+ SM + L +
Sbjct: 208 DESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGD-----EISMMLVLSRQEV 262
Query: 247 GLPSLIEKLASESCFLK--GKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSK 304
L +L E L + + +QKV V +P+F + E++ +VLK LG+ F K
Sbjct: 263 PLATL-EPLVKAQLVEEWANSVKKQKVEV---YLPRFTVEQEIDLKDVLKALGITEIFIK 318
Query: 305 SNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVAD 364
+AN T + S E+ + HK+ +EVNEEG+EA M + + A + D
Sbjct: 319 -DANLTGL--SDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGM--IAISRMAVLYPQVIVD 373
Query: 365 HPFLFLIREDLTGTILFIGQVLHPE 389
HPF FLIR TGTILF+G+V+HPE
Sbjct: 374 HPFFFLIRNRRTGTILFMGRVMHPE 398
>ILEU_HUMAN (P30740) Leukocyte elastase inhibitor (LEI)
(Monocyte/neutrophil elastase inhibitor) (M/NEI) (EI)
Length = 379
Score = 156 bits (395), Expect = 8e-38
Identities = 114/363 (31%), Positives = 177/363 (48%), Gaps = 15/363 (4%)
Query: 31 NLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLNTFFSQVLSTVLSDTTPSFL 90
N+ SPFS+ + ++++ +G+ G+T +L F++V+ +++ F Q L+ ++ S++
Sbjct: 27 NIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRF-QSLNADINKRGASYI 85
Query: 91 LSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQVCREVNSWVEKETNGLIT 150
L N ++ +K+ F Y A LA VDF+ + + +N WV+ +T G I
Sbjct: 86 LKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIP 145
Query: 151 ELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHLLNGTSIEVPFMSSEKKTQ 210
ELL + V +TKL+ NA+YFKG WK F T F L V M +KK
Sbjct: 146 ELLASGMVDNMTKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFA 205
Query: 211 FIRTFD-GFNVLRLSYKQGRDKKLRFSMCIFLP----NAKDGLPSLIEKLASESCFLKGK 265
+ D VL L Y QG + SM I LP + GL + E+L E K
Sbjct: 206 YGYIEDLKCRVLELPY-QGEE----LSMVILLPDDIEDESTGLKKIEEQLTLEKLHEWTK 260
Query: 266 LPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSNANFTKMVVSPLDELCVESI 325
+P+FK+ ++ L LGV F+ S A+ + M S ++ + I
Sbjct: 261 PENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGM--SGARDIFISKI 318
Query: 326 HHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVADHPFLFLIREDLTGTILFIGQV 385
HK+ +EVNEEGTEA A + + +F ADHPFLF IR + +G+ILF+G+
Sbjct: 319 VHKSFVEVNEEGTEA--AAATAGIATFCMLMPEENFTADHPFLFFIRHNSSGSILFLGRF 376
Query: 386 LHP 388
P
Sbjct: 377 SSP 379
>NEUS_MOUSE (O35684) Neuroserpin precursor (Protease inhibitor 17)
Length = 410
Score = 155 bits (392), Expect = 2e-37
Identities = 115/388 (29%), Positives = 192/388 (48%), Gaps = 25/388 (6%)
Query: 11 TEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHL 70
TE ++++ HL E ++N++FSP S+ + +M +G+ GST E+ + ++ +
Sbjct: 27 TEWSVNMYNHLRGTGE--DENILFSPLSIALAMGMMELGAQGSTRKEIRHSMGYEGLKGG 84
Query: 71 NTF-FSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTK 129
F F + S + S +++ N ++ ++ F Q++ ++ A + VDF ++
Sbjct: 85 EEFSFLRDFSNMASAEENQYVMKLANSLFVQNGFHVNEEFLQMLKMYFNAEVNHVDF-SQ 143
Query: 130 GDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDD 189
V +N WVE TN L+ +L+ +T L NA+YFKG WK F P T
Sbjct: 144 NVAVANSINKWVENYTNSLLKDLVSPEDFDGVTNLALINAVYFKGNWKSQFRPENTRTFS 203
Query: 190 FHLLNGTSIEVPFMSSEKKTQFIRTFDGFN-------VLRLSYKQGRDKKLRFSMCIFLP 242
F + + +++P M + + + DG N VL + Y+ SM + L
Sbjct: 204 FTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGD-----EISMMLALS 258
Query: 243 NAKDGLPSLIEKLASESC-FLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSP 301
+ L +L L ++ + +QKV V +P+F + E++ ++LK LGV
Sbjct: 259 RQEVPLATLEPLLKAQLIEEWANSVKKQKVEV---YLPRFTVEQEIDLKDILKALGVTEI 315
Query: 302 FSKSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDF 361
F K +AN T M S EL + HK+ IEVNEEG+EA A M + + A
Sbjct: 316 FIK-DANLTAM--SDKKELFLSKAVHKSCIEVNEEGSEAAAASGM--IAISRMAVLYPQV 370
Query: 362 VADHPFLFLIREDLTGTILFIGQVLHPE 389
+ DHPFL+LIR +G ILF+G+V++PE
Sbjct: 371 IVDHPFLYLIRNRKSGIILFMGRVMNPE 398
>PTI6_HUMAN (P35237) Placental thrombin inhibitor (Cytoplasmic
antiproteinase) (CAP) (Protease inhibitor 6) (PI-6)
Length = 376
Score = 154 bits (388), Expect = 5e-37
Identities = 110/364 (30%), Positives = 180/364 (49%), Gaps = 17/364 (4%)
Query: 30 KNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLNTFFS--QVLSTVLSDTTP 87
KN+ FSP S+ L+++ +G+ G+T ++ L F+ Q L T ++ T
Sbjct: 25 KNVFFSPMSMSCALAMVYMGAKGNTAAQMAQILSFNKSGGGGDIHQGFQSLLTEVNKTGT 84
Query: 88 SFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQVCREVNSWVEKETNG 147
+LL N ++ +KS SF+ Y+A + +DF + ++ + +N+WV ++T G
Sbjct: 85 QYLLRVANRLFGEKSCDFLSSFRDSCQKFYQAEMEELDFISAVEKSRKHINTWVAEKTEG 144
Query: 148 LITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHLLNGTSIEVPFMSSEK 207
I ELL +V LT+L+ NA+YF+G W FD T F + + E P K
Sbjct: 145 KIAELLSPGSVDPLTRLVLVNAVYFRGNWDEQFDKENTEERLFKV--SKNEEKPVQMMFK 202
Query: 208 KTQFIRTFDG---FNVLRLSYKQGRDKKLRFSMCIFLPNAKDGLPSLIEKLASESCFLKG 264
++ F +T+ G +L L Y G++ +M I LP+ L ++ ++L E
Sbjct: 203 QSTFKKTYIGEIFTQILVLPY-VGKE----LNMIIMLPDETTDLRTVEKELTYEKFVEWT 257
Query: 265 KLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSNANFTKMVVSPLDELCVES 324
+L + +P+FK+ + +VL+ LG+ F A+F+ M + +L +
Sbjct: 258 RLDMMDEEEVEVSLPRFKLEESYDMESVLRNLGMTDAFELGKADFSGMSQT---DLSLSK 314
Query: 325 IHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVADHPFLFLIREDLTGTILFIGQ 384
+ HK+ +EVNEEGTEA A + + C AR F ADHPFLF I+ T ILF G+
Sbjct: 315 VVHKSFVEVNEEGTEAAAATAAIMMMRC--ARFVPRFCADHPFLFFIQHSKTNGILFCGR 372
Query: 385 VLHP 388
P
Sbjct: 373 FSSP 376
>PAI1_RAT (P20961) Plasminogen activator inhibitor-1 precursor
(PAI-1) (Endothelial plasminogen activator inhibitor)
(PAI)
Length = 402
Score = 153 bits (386), Expect = 9e-37
Identities = 113/383 (29%), Positives = 193/383 (49%), Gaps = 21/383 (5%)
Query: 11 TEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHL 70
T + + +H+ + ++N+VFSP+ + ++L+++ + +AG T ++ + F+ +
Sbjct: 36 TNFGVKVFQHVVQASK--DRNVVFSPYGVSSVLAMLQLTTAGKTRQQIQDAMGFNISERG 93
Query: 71 NTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKG 130
+ LS L + +S + ++ + L L F ++ T+ VDF ++
Sbjct: 94 TAPALRKLSKELMGSWNKNEISTADAIFVQRDLELVQGFMPHFFKLFRTTVKQVDF-SEV 152
Query: 131 DQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDF 190
++ +N WVE+ T G+I++LL AV++LT+L+ NALYF G WK F + T F
Sbjct: 153 ERARFIINDWVERHTKGMISDLLAKGAVNELTRLVLVNALYFNGQWKTPFLEASTHQRLF 212
Query: 191 HLLNGTSIEVPFMSSEKKTQF--IRTFDG--FNVLRLSYKQGRDKKLRFSMCIFLPNAKD 246
H +G++I VP M+ K + T DG +++L L Y SM I P KD
Sbjct: 213 HKSDGSTISVPMMAQNNKFNYTEFTTPDGHEYDILELPYHGE-----TLSMFIAAPFEKD 267
Query: 247 GLPSLIEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSN 306
S I + + K ++ R +PKF + E++ L++LG+ FS +
Sbjct: 268 VPLSAITNILDAELIRQWKSNMTRL-PRLLILPKFSLETEVDLRGPLEKLGMTDIFSSTQ 326
Query: 307 ANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTG-IDFVADH 365
A+FT + S ++L V K IEVNE GT A + + + VSAR + V D
Sbjct: 327 ADFTSL--SDQEQLSVAQALQKVKIEVNESGTVASSSTA-----ILVSARMAPTEMVLDR 379
Query: 366 PFLFLIREDLTGTILFIGQVLHP 388
FLF++R + T TILF+GQ++ P
Sbjct: 380 SFLFVVRHNPTETILFMGQLMEP 402
>SCC1_HUMAN (P29508) Squamous cell carcinoma antigen 1 (SCCA-1)
(Protein T4-A)
Length = 390
Score = 152 bits (385), Expect = 1e-36
Identities = 107/377 (28%), Positives = 178/377 (46%), Gaps = 25/377 (6%)
Query: 28 QEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDHLNTFFS------------ 75
+E N+ +SP S+ + L ++ +G+ +T ++ L FD V T +
Sbjct: 23 KENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRSGNVH 82
Query: 76 ---QVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQ 132
Q L T + +T ++ L N+++ +K+ + + Y+ ++ VDF ++
Sbjct: 83 HQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEE 142
Query: 133 VCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHL 192
+++NSWVE +TN I L+P + T L+ NA+YFKG W+ F+ T + F
Sbjct: 143 SRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWP 202
Query: 193 LNGTSIEVPFMSSEKKTQFIRTFD-GFNVLRLSYKQGRDKKLRFSMCIFLPNAKDGLPSL 251
T + M F D VL + YK G+D SM + LPN DGL L
Sbjct: 203 NKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYK-GKD----LSMIVLLPNEIDGLQKL 257
Query: 252 IEKLASESCFLKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSNANFTK 311
EKL +E L + +P+FK+ + + L+ +G+V F+ +A+ +
Sbjct: 258 EEKLTAEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVDIFN-GDADLSG 316
Query: 312 MVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVADHPFLFLI 371
M S L + + HKA +EV EEG EA A ++ ++ T +F +HPFLF I
Sbjct: 317 MTGS--RGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTS-TNEEFHCNHPFLFFI 373
Query: 372 REDLTGTILFIGQVLHP 388
R++ T +ILF G+ P
Sbjct: 374 RQNKTNSILFYGRFSSP 390
>SPB8_HUMAN (P50452) Cytoplasmic antiproteinase 2 (CAP2) (CAP-2)
(Protease inhibitor 8) (Serpin B8)
Length = 374
Score = 152 bits (384), Expect = 1e-36
Identities = 117/385 (30%), Positives = 182/385 (46%), Gaps = 20/385 (5%)
Query: 9 CQTEVALSITKHLFSKEEYQEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVD 68
C+ +I+ EE +N+ FSP S+ + L+++ +G+ GST ++ L
Sbjct: 5 CEANGTFAISLFKILGEEDNSRNVFFSPMSISSALAMVFMGAKGSTAAQMSQALCLYKDG 64
Query: 69 HLNTFFSQVLSTVLSDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRT 128
++ F +LS V + T +LL N ++ +K+ FK+ Y+A L + F
Sbjct: 65 DIHRGFQSLLSEV-NRTGTQYLLRTANRLFGEKTCDFLPDFKEYCQKFYQAELEELSFAE 123
Query: 129 KGDQVCREVNSWVEKETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVD 188
++ + +N WV ++T G I+E+L V LTKL+ NA+YFKG W FD T
Sbjct: 124 DTEECRKHINDWVAEKTEGKISEVLDAGTVDPLTKLVLVNAIYFKGKWNEQFDRKYTRGM 183
Query: 189 DFHLLNGTSIEVPFMSSEKKTQFIRTFD-GFNVLRLSYKQGRDKKLRFSMCIFLPNAKDG 247
F N V M E K + + VL L Y + SM I LP+
Sbjct: 184 LFK-TNEEKKTVQMMFKEAKFKMGYADEVHTQVLELPYVEE-----ELSMVILLPDDNTD 237
Query: 248 LPSLIEKLASESCFL----KGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFS 303
L +++EK + F KL + KV+V +P+ K+ + L+ LG++ F
Sbjct: 238 L-AVVEKALTYEKFKAWTNSEKLTKSKVQV---FLPRLKLEESYDLEPFLRRLGMIDAFD 293
Query: 304 KSNANFTKMVVSPLDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTGIDFVA 363
++ A+F+ M S + + + HK +EVNEEGTEA A ++ C +R F A
Sbjct: 294 EAKADFSGM--STEKNVPLSKVAHKCFVEVNEEGTEAAAATAVVRNSRC--SRMEPRFCA 349
Query: 364 DHPFLFLIREDLTGTILFIGQVLHP 388
DHPFLF IR T ILF G+ P
Sbjct: 350 DHPFLFFIRRHKTNCILFCGRFSSP 374
>PAI1_MUSVI (P50449) Plasminogen activator inhibitor-1 precursor
(PAI-1) (Endothelial plasminogen activator inhibitor)
(PAI)
Length = 400
Score = 152 bits (383), Expect = 2e-36
Identities = 111/373 (29%), Positives = 186/373 (49%), Gaps = 33/373 (8%)
Query: 28 QEKNLVFSPFSLHAILSVMAVGSAGSTLDELFSFLRFDSVDH-----LNTFFSQVLSTVL 82
+++N+VFSP+ L ++L+++ + +AG T ++ +RF + L + +++
Sbjct: 49 KDRNMVFSPYGLASVLAMLQLTTAGETRQQIQEAMRFQIDEKGMAPALRQLYKELMGPWN 108
Query: 83 SDTTPSFLLSFVNEMWADKSLALSHSFKQLMTTHYKATLALVDFRTKGDQVCREVNSWVE 142
D +S + ++ + L L H F ++ T+ VDF ++ ++ +N WV+
Sbjct: 109 KDE-----ISTADAIFVQRDLKLVHGFMPYFFRLFQTTVKQVDF-SEVERARFIINDWVK 162
Query: 143 KETNGLITELLPTNAVHKLTKLIFANALYFKGVWKHTFDPSMTFVDDFHLLNGTSIEVPF 202
+ T G+I +LL V +LT+L+ NALYF G WK F S T FH +G+++ VP
Sbjct: 163 RHTKGMIGDLLGRGTVDQLTRLMLVNALYFNGQWKTPFPKSGTHHRLFHKSDGSTVSVPM 222
Query: 203 MSSEKKTQF--IRTFDG--FNVLRLSYKQGRDKKLRFSMCIFLPNAKDGLPSLIEKLASE 258
M+ K + T +G +++L L Y SM I P KD S + +
Sbjct: 223 MAQTNKFNYTEFSTPEGRYYDILELPYHGD-----TLSMFIAAPYEKDVPLSALTNILDA 277
Query: 259 SCF--LKGKLPRQKVRVRKFRIPKFKICFELEASNVLKELGVVSPFSKSNANFTKMVVSP 316
KG + R R+R +PKF + E+ L+ LG+ F + A+F+ + S
Sbjct: 278 QLISQWKGNMTR---RLRLLVLPKFSLESEVNLRGPLENLGMTDMFRPNQADFSSL--SD 332
Query: 317 LDELCVESIHHKASIEVNEEGTEAGVACSMCDVKLCVSARTG-IDFVADHPFLFLIREDL 375
+ L V K IEVNE GT A + + + VSAR + + D PFLF++R +
Sbjct: 333 QEALYVSQALQKVKIEVNESGTVASSSTA-----IIVSARMAPEEIIMDRPFLFVVRHNP 387
Query: 376 TGTILFIGQVLHP 388
TGT+LF+GQV+ P
Sbjct: 388 TGTVLFMGQVMEP 400
Database: sprot
Posted date: Nov 25, 2004 10:54 AM
Number of letters in database: 59,974,054
Number of sequences in database: 164,201
Lambda K H
0.323 0.136 0.397
Gapped
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 44,391,215
Number of Sequences: 164201
Number of extensions: 1802831
Number of successful extensions: 4537
Number of sequences better than 10.0: 153
Number of HSP's better than 10.0 without gapping: 135
Number of HSP's successfully gapped in prelim test: 18
Number of HSP's that attempted gapping in prelim test: 3880
Number of HSP's gapped (non-prelim): 165
length of query: 402
length of database: 59,974,054
effective HSP length: 112
effective length of query: 290
effective length of database: 41,583,542
effective search space: 12059227180
effective search space used: 12059227180
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 67 (30.4 bits)
Lotus: description of TM0175.7